Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

This session will cover the Development Safety Update Report (DSUR) required in the EU and include a description of the modifications required for the DSUR submission to FDA in lieu of the IND Annual Report.

• Introduction/background
• General principles
• Format and contents of DSUR
• Practical points to consider in preparing a DSUR